TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,761 | +16.3% | 14,141 | +18.1% | 0.00% | +50.0% |
| Q2 2023 | $188,096 | -1.9% | 11,973 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $191,728 | -35.4% | 11,634 | -49.2% | 0.00% | -50.0% |
| Q3 2022 | $297,000 | -26.8% | 22,884 | -20.9% | 0.00% | -33.3% |
| Q2 2022 | $406,000 | -37.2% | 28,918 | -35.9% | 0.01% | -25.0% |
| Q1 2022 | $646,000 | +54.9% | 45,086 | +47.3% | 0.01% | +60.0% |
| Q4 2021 | $417,000 | +10.9% | 30,602 | +33.5% | 0.01% | 0.0% |
| Q3 2021 | $376,000 | +30.6% | 22,928 | +33.8% | 0.01% | +25.0% |
| Q2 2021 | $288,000 | -36.1% | 17,132 | -30.6% | 0.00% | -33.3% |
| Q1 2021 | $451,000 | +29.6% | 24,696 | +26.6% | 0.01% | +20.0% |
| Q3 2020 | $348,000 | +37.0% | 19,502 | +37.6% | 0.01% | +25.0% |
| Q2 2020 | $254,000 | -33.5% | 14,178 | -26.9% | 0.00% | -33.3% |
| Q4 2019 | $382,000 | -2.1% | 19,386 | -14.6% | 0.01% | 0.0% |
| Q3 2019 | $390,000 | +17.8% | 22,688 | +39.6% | 0.01% | +20.0% |
| Q1 2019 | $331,000 | – | 16,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |